Focal lysolecithin-induced demyelination of peripheral afferents results in neuropathic pain behavior that is attenuated by cannabinoids

Journal of Neuroscience

Volumn 23, Issue 8, 2003, Pages 3221-3233

  Wallace, Victoria C J ^a   Cottrell, David F ^a   Brophy, Peter J ^a   Fleetwood Walker, Susan M ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Afferents; Cannabinoids; Demyelination; DRG; Neuropathic pain; Sodium channels

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (3 PHOSPHONOPROPYL) 2 PIPERAZINECARBOXYLIC ACID; CANNABINOID; CANNABINOID RECEPTOR AGONIST; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; LYSOPHOSPHATIDYLCHOLINE; MU OPIATE RECEPTOR AGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPEPTIDE Y; SODIUM CHANNEL; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEMYELINATION; ELECTRON MICROSCOPY; EVOKED SOMATOSENSORY RESPONSE; IMMUNOHISTOCHEMISTRY; MECHANICAL STIMULATION; MOUSE; NEUROPATHIC PAIN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SAPHENOUS NERVE; SCIATIC NERVE; SENSORY NERVE; SPINAL GANGLION; THERMAL STIMULATION;

EID: 0037996903     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.23-08-03221.2003     Document Type: Article

References (103)

1. Akopian AN, Sivilotti L, Wood JN (1996) A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature 379:257-262.
2. Amaya F, Decosterd I, Samad TA, Plumpton C, Tate S, Mannion RJ, Costigan M, Woolf CJ (2000) Diversity of expression of the sensory neuron-specific TTX-resistant voltage-gated sodium ion channels SNS and SNS2. Mol Cell Neurosci 15:331-342.
3. Arner S, Meyerson BA (1988) Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 33:11-23.
4. Asbury AK (1990) Guillain-Barre syndrome: historical aspects. Ann Neurol [Suppl] 27:S2-S6.
5. Bennett DL, Michael GJ, Ramachandran N, Munson JB, Averill S, Yan Q, McMahon SB, Priestley JV (1998) A distinct subgroup of small DRG cells express GDNF receptor components and GDNF is protective for these neurons after nerve injury. J Neurosci 18:3059-3072.
6. Bennett GJ (1994) Animal models of neuropathic pain. In: Proceedings of the 7th World Congress on Pain, Vol 2 (Gebhart GF, Hammond DL, Jensen TS, eds), pp 495-510. Seattle: IASP.
7. Black JA, Waxman SG (1996) Sodium channel expression: a dynamic process in neurons and non-neuronal cells. Dev Neurosci 18:139-152.
8. Black JA, Cummins TR, Plumpton C, Chen YH, Hormuzdiar W, Clare JJ, Waxman SG (1999) Upregulation of a silent sodium channel after peripheral, but not central, nerve injury in DRG neurons. J Neurophysiol 82:2776-2785.
9. Boerkoel CF, Takashima H, Stankiewicz P, Garcia CA, Leber SM, Rhee-Morris L, Lupski JR (2001) Periaxin mutations cause recessive Dejerine-Sottas neuropathy. Am J Hum Genet 68:325-333.
10. Bridges D, Ahmad K, Rice AS (2001) The synthetic cannabinoid WIN55, 212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain. Br J Pharmacol 133:586-594.
11. Carter GT, Jensen MP, Galer BS, Kraft GH, Crabtree LD, Beardsley RM, Abresch RT, Bird TD (1998) Neuropathic pain in Charcot-Marie-Tooth disease. Arch Phys Med Rehabil 79:1560-1564.
12. Chabal C, Jacobson L, Russell LC, Burchiel KJ (1992) Pain response to perineuromal injection of normal saline, epinephrine, and lidocaine in humans. Pain 49:9-12.
13. Chaplan SR, Malmberg AB, Yaksh TL (1997) Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat. J Pharmacol Exp Ther 280:829-838.
14. Chapman V (2001) Functional changes in the inhibitory effect of spinal cannabinoid (CB) receptor activation in nerve injured rats. Neuropharmacology 41:870-877.
15. Codderre TJ, Melzack R (1992) The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci 12:3665-3670.
16. Constoe P, Musty R, Rein J, Tillery W, Pertwee R (1997) The perceived effects of smoked cannabis on patients with multiple sclerosis. Eur Neurol 38:44-48.
17. Cummins TR, Waxman SG (1997) Downregulation of tetrodotoxin-resistant sodium currents and upregulation of a rapidly repriming tetrodotoxin-sensitive sodium current in small spinal sensory neurons after nerve injury. J Neurosci 17:3503-3514.
18. Decosterd I, Ji RR, Abdi S, Tate S, Woolf CJ (2002) The pattern of expression of the voltage-gated sodium channels Na(v)1.8 and Na(v)1.9 does not change in uninjured primary sensory neurons in experimental neuropathic pain models. Pain 96:269-277.
19. Delague V, Bareil C, Tuffery S, Bouvagnet P, Chouery E, Koussa S, Maisonobe T, Loiselet J, Megarbane A, Claustres M (2000) Mapping of a new locus for autosomal recessive demyelinating Charcot-Marie-Tooth disease to 19q13.1-13.3 in a large consanguineous Lebanese family: exclusion of MAG as a candidate gene. Am J Hum Genet 67:236-243.
20. Devor M, Seltzer Z (1999) Pathophysiology of damaged nerves in relation to chronic pain. In: Textbook of pain (Wall PD, Melzack R, eds), pp 129-164. London: Churchill Livingstone.
21. Devor M, Wall PD, Catalan N (1992) Systemic lidocaine silences ectopic neuroma and DRG discharge without blocking nerve conduction. Pain 48:261-268.
22. Devor M, Janig W, Michaelis M (1994) Modulation of activity in dorsal root ganglion neurons by sympathetic activation in nerve-injured rats. J Neurophysiol 71:38-47.
23. Dib-Hajj S, Black JA, Felts P, Waxman SG (1996) Down-regulation of transcripts for Na channel alpha-SNS in spinal sensory neurons following axotomy. Proc Natl Acad Sci USA 93:14950-14954.
24. Dib-Hajj SD, Fjell J, Cummins TR, Zheng Z, Fried K, LaMotte R, Black JA, Waxman SG (1999) Plasticity of sodium channel expression in DRG neurons in the chronic constriction injury model of neuropathic pain. Pain 83:591-600.
25. Dickenson AH, Sullivan AF (1987) Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fiber stimulation. Neuropharmacology 26:1235-1238.
26. Doughty SE, Atkinson ME, Shehab SA (1991) A quantitative study of neuropeptide immunoreactive cell bodies of primary afferent sensory neurons following rat sciatic nerve peripheral axotomy. Regul Pept 35:59-72.
27. Dray A, Urban L, Dickenson A (1994) Pharmacology of chronic pain. Trends Pharmacol Sci 15:190-197.
28. Dumoulin FL, Raivich G, Haas CA, Lazar P, Reddington M, Streit WJ, Kreutzberg GW (1992) Calcitonin gene-related peptide and peripheral nerve regeneration. Ann NY Acad Sci 657:351-360.
29. Eliav E, Herzberg U, Ruda MA, Bennett GJ (1999) Neuropathic pain from an experimental neuritis of the rat sciatic nerve. Pain 83:169-182.
30. Fleetwood-Walker SM, Hope PJ, Mitchell R, el Yassir N, Molony V (1988) The influence of opioid receptor subtypes on the processing of nociceptive inputs in the spinal dorsal horn of the cat. Brain Res 451:213-226.
31. Fox A, Kesingland A, Gentry C, McNair K, Patel S, Urban L, James I (2001) The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain. Pain 92:91-100.
32. Garry EM, Moss A, Delaney A, O'Neill F, Blakemore J, Bowen J, Husi M, Mitchell R, Grant SGN, Fleetwood-Walker SM (2003) Neuropathicsensitisation of behavioral reflexes and spinal NMDA receptor/CaM kinase II interactions are disrupted in PSD-95 mutant mice. Curr Biol 13:321-328.
33. Gibson SJ, Polak JM, Bloom SR, Sabate IM, Mulderry PM, Ghatei MA, McGregor GP, Morrison JF, Kelly JS, Evans RM (1984) Calcitonin gene-related peptide immunoreactivity in the spinal cord of man and of eight other species. J Neurosci 4:3101-3111.
34. Gillespie CS, Sherman DL, Fleetwood-Walker SM, Cottrell DF, Tait S, Garry EM, Wallace VC, Ure J, Griffiths IR, Smith A, Brophy PJ (2000) Peripheral demyelination and neuropathic pain behavior in periaxin-deficient mice. Neuron 26:523-531.
35. Goldstein ME, House SB, Gainer H (1991) NF-L and peripherin immunoreactivities define distinct classes of rat sensory ganglion cells. J Neurosci Res 30:92-104.
36. Guilbot A, Williams A, Ravise N, Verny C, Brice A, Sherman DL, Brophy PJ, LeGuern E, Delague V, Bareil C, Megarbane A, Claustres M (2001) A mutation in periaxin is responsible for CMT4F, an autosomal recessive form of Charcot-Marie-Tooth disease. Hum Mol Genet 10:415-421.
37. Hai T, Wolfgang CD, Marsee DK, Allen AE, Sivaprasad U (1999) ATF3 and stress responses. Gene Exp 7:321-335.
38. Hall SM, Gregson NA (1971) The in vivo and ultrastructural effects of injection of lysophosphatidyl choline into myelinated peripheral nerve fibers of the adult mouse. J Cell Sci 9:769-789.
39. Hargreaves K, Dubner R, Brown FFC, Jovis J (1988) A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32:77-88.
40. Herzberg U, Eliav E, Bennett GJ, Kopin IJ (1997) The analgesic effects of R(+)-WIN 55, 212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain. Neurosci Lett 221:157-160.
41. Hokfelt T, Wiesenfeld-Hallin Z, Villar M, Melander T (1987) Increase of galanin-like immunoreactivity in rat dorsal root ganglion cells after peripheral axotomy. Neurosci Lett 83:217-220.
42. Hokfelt T, Zhang X, Wiesenfeld-Hallin Z (1994) Messenger plasticity in primary sensory neurons following axotomy and its functional implications. Trends Neurosci 17:22-30.
43. Iggo A (1958) The electrophysiological identification of single nerve fibers with particular reference to the slowly conducting vagal afferent fibers in the cat. J Physiol (Lond) 142:110-126.
44. Kashiba H, Senba E, Kawai Y, Ueda Y, Tohyama M (1992) Axonal blockade induces the expression of vasoactive intestinal polypeptide and galanin in rat dorsal root ganglion neurons. Brain Res 577:19-28.
45. Kashiba H, Noguchi K, Ueda Y, Senba E (1994) Neuropeptide Y and galanin are coexpressed in rat large type A sensory neurons after peripheral transection. Peptides 15:411-416.
46. Kelly S, Chapman V (2001) Selective cannabinoid CB1 receptor activation inhibits spinal nociceptive transmission in vivo. J Neurophysiol 86:3061-3064.
47. Kerr BJ, Wynick D, Thompson SW, McMahon SB (2000) The biological role of galanin in normal and neuropathic states. Prog Brain Res 129:219-230.
48. Kim CH, Oh Y, Chung JM, Chung K (2001) The changes in expression of three subtypes of TTX sensitive sodium channels in sensory neurons after spinal nerve ligation. Brain Res Mol Brain Res 95:153-161.
49. Koltzenburg M (1998) Painful neuropathies. Curr Opin Neurol 11:515-521.
50. Lawson SN, Waddell PJ (1991) Soma neurofilament immunoreactivity is related to cell size and fiber conduction velocity in rat primary sensory neurons. J Physiol (Lond) 435:41-63.
51. Lee YW, Chaplan SR, Yaksh TL (1995) Systemic and supraspinal, but not spinal, opiates suppress allodynia in a rat neuropathic pain model. Neurosci Lett 199:111-114.
52. Lehmann J, Schneider J, McPherson S, Murphy DE, Bernard P, Tsai C, Bennett DA, Pastor G, Steel DJ, Boehm C (1987) CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo. J Pharmacol Exp Ther 240:737-746.
53. Liu CN, Wall PD, Ben Dor E, Michaelis M, Amir R, Devor M (2000) Tactile allodynia in the absence of C-fiber activation: altered firing properties of DRG neurons following spinal nerve injury. Pain 85:503-521.
54. Liu X, Eschenfelder S, Blenk KH, Janig W, Habler H (2000) Spontaneous activity of axotomized afferent neurons after L5 spinal nerve injuryin rats. Pain 84:309-318.
55. Love S, Jacobs JM, Myers R (1986) Chronic demyelination in mouse peripheral nerve produced by lysophosphatidyl choline and X-irradiation: ultrastructural observations. J Neurocytol 15:155-167.
56. Lundberg JM, Terenius L, Hokfelt T, Goldstein M (1983) High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man. Neurosci Lett 42:167-172.
57. Ma W, Bisby MA (1998) Partial and complete sciatic nerve injuries induce similar increases of neuropeptide Y and vasoactive intestinal peptide immunoreactivities in primary sensory neurons and their central projections. Neuroscience 86:1217-1234.
58. Malmberg AB, Yaksh TL (1993) Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction. Anesthesiology 79:270-281.
59. Mao J, Price DD, Hayes RL, Lu J, Mayer DJ, Frenk H (1993) Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy. Brain Res 605:164-168.
60. Marchand JE, Cepeda MS, Carr DB, Wurm WH, Kream RM (1999) Alterations in neuropeptide Y, tyrosine hydroxylase, and Y-receptor subtype distribution following spinal nerve injury to rats. Pain 79:187-200.
61. Martin WJ, Loo CM, Basbaum AI (1999) Spinal cannabinoids are antiallodynic in rats with persistent inflammation. Pain 82:199-205.
62. Matzner O, Devor M (1992) Na+ conductance and the threshold for repetitive neuronal firing. Brain Res 597:92-98.
63. Matzner O, Devor M (1994) Hyperexcitability at sites of nerve injury depends on voltage-sensitive Na+ channels. J Neurophysiol 72:349-359.
64. McCarthy PW, Lawson SN (1990) Cell type and conduction velocity of rat primary sensory neurons with calcitonin gene-related peptide-like immunoreactivity. Neuroscience 34:623-632.
65. Meyer OA, Tilson HA, Byrd WC, Riley MT (1979) A method for the routine assessment of fore- and hindlimbs grip strength of rats and mice, Neurobehav Toxicol 1:233-236.
66. Michael GJ, Averill S, Shortland PJ, Yan Q, Priestley JV (1999) Axotomy results in major changes in BDNF expression by dorsal root ganglion cells: BDNF expression in large trkB and trkC cells, in pericellular baskets, and in projections to deep dorsal horn and dorsal column nuclei. Eur J Neurosci 11:3539-3551.
67. Mitchell J, Caren CA (1982) Degeneration of non-myelinated axons in the rat sciatic nerve following lysolecithin injection. Acta Neuropathol (Berl) 56:187-193.
68. Moulin DE (1998) Pain in central and peripheral demyelinating disorders: multiple sclerosis and Guilain-Barre syndrome. Neurol Clin 16:889-897.
69. Munglani R, Bond A, Smith GD, Harrison SM, Elliot PJ, Birch PJ, Hunt SP (1995) Changes in neuronal markers in a mononeuropathic rat model relationship between neuropeptide Y, pre-emptive drug treatment and long-term mechanical hyperalgesia. Pain 63:21-31.
70. Nahin RL, Ren K, De Leon M, Ruda M (1994) Primary sensory neurons exhibit altered gene expression in a rat model of neuropathic pain. Pain 58:95-108.
71. Noguchi K, Senba E, Morita Y, Sato M, Tohyama M (1990) Alpha-CGRP and beta-CGRP mRNAs are differentially regulated in the rat spinal cord and dorsal root ganglion. Brain Res Mol Brain Res 7:299-304.
72. Noguchi K, De Leon M, Nahin RL, Senba E, Ruda MA (1993) Quantification of axotomy-induced alteration of neuropeptide mRNAs in dorsal root ganglion neurons with special reference to neuropeptide Y mRNA and the effects of neonatal capsaicin treatment. J Neurosci Res 35:54-66.
73. Novakovic SD, Tzoumaka E, McGivern JG, Haraguchi M, Sangameswaran L, Gogas KR, Eglen RM, Hunter JC (1998) Distribution of the tetrodotoxin-resistant sodium channel PN3 in rat sensory neurons in normal and neuropathic conditions. J Neurosci 18:2174-2187.
74. Omana-Zapata I, Khabbaz MA, Hunter JC, Clarke DE, Bley KR (1997) Tetrodotoxin inhibits neuropathic ectopic activity in neuromas, dorsal root ganglia and dorsal horn neurons. Pain 72:41-49.
75. Pentland B, Donald SM (1994) Pain in the Guillain-Barre syndrome: a clinical review. Pain 59:159-164.
76. Polgar E, Shehab SA, Watt C, Todd AJ (1999) GABAergic neurons that contain neuropeptide Y selectively target cells with the neurokinin 1 receptor in laminas III and IV of the rat spinal cord. J Neurosci 19:2637-2646.
77. Rasminsky M (1981) Hyperexcitability of pathologically myelinated axons and positive symptoms in multiple sclerosis. Adv Neurol 31:289-297.
78. Richardson JD, Aanonsen L, Hargreaves KM (1998a) Antihyperalgesic effects of spinal cannabinoids. Eur J Pharmacol 345:145-153.
79. Richardson JD, Kilo S, Hargreaves KM (1998b) Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain 75:111-119.
80. Rittenhouse PA, Marchand JE, Chen J, Kream RM, Leeman SE (1996) Streptozotocin-induced diabetes is associated with altered expression of peptide-encoding mRNAs in rat sensory neurons. Peptides 17:1017-1022.
81. Rizzo MA (1997) Successful treatment of painful traumatic mononeuropathy with carbamazepine: insights into a possible molecular pain mechanism. J Neurol Sci 152:103-106.
82. Robson P (2001) Therapeutic aspects of cannabis and cannabinoids. Br J Psychiatry 178:107-115.
83. Rosenfeld MG, Mermod JJ, Amara SG, Swanson LW, Sawchenko PE, Rivier J, Vale WW, Evans RM (1983) Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing. Nature 304:129-135.
84. Sakurada S, Zadina JE, Kastin AJ, Katsuyama S, Fujimura T, Murayama K, Yuki M, Ueda H (1999) Differential involvement of mu-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception. Eur J Pharmacol 372:25-30.
85. Sakurada S, Hayashi T, Yuhki M, Orito T, Zadina JE, Kastin AJ, Fujimura T, Murayama K, Sakurada C, Sakurada T, Narita M, Suzuki T, Tan-no K, Tseng LF (2001) Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse. Eur J Pharmacol 427:203-210.
86. Sangameswaran L, Delgado SG, Fish LM, Koch BD, Jakeman LB, Stewart GR, Sze P, Hunter JC, Eglen RM, Herman RC (1996) Structure and function of a novel voltage-gated, tetrodotoxin-resistant sodium channel specific to sensory neurons. J Biol Chem 271:5953-5956.
87. Takashima H, Boerkoel CF, De Jonghe P, Ceuterick C, Martin JJ, Voit T, Schroder JM, Williams A, Brophy PJ, Timmerman V, Lupski JR (2002) Periaxin mutations cause a broad spectrum of demyelinating neuropathies. Ann Neurol 51:709-715.
88. Todd AJ (1997) A method for combining confocal and electron microscopic examination of sections processed for double- or triple-labeling immunocytochemistry. J Neurosci Methods 73:149-157.
89. Tsujino H, Kondo E, Fukuoka T, Dai Y, Tokunaga A, Miki K, Yonenobu K, Ochi T, Noguchi K (2000) Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: a novel neuronal marker of nerve injury, Mol Cell Neurosci 15:170-182.
90. Villar MJ, Cortes R, Theodorsson E, Wiesenfeld-Hallin Z, Schalling M, Fahrenkrug J, Emson PC, Hokfelt T (1989) Neuropeptide expression in rat dorsal root ganglion cells and spinal cord after peripheral nerve injury with special reference to galanin. Neuroscience 33:587-604.
91. Villar MJ, Wiesenfeld-Hallin Z, Xu XJ, Theodorsson E, Emson PC, Hokfelt T (1991) Further studies on galanin-, substance P-, and CGRP-like immunoreactivities in primary sensory neurons and spinal cord: effects of dorsal rhizotomies and sciatic nerve lesions. Exp Neurol 112:29-39.
92. Wakisaka S, Kajander KC, Bennett GJ (1991) Increased neuropeptide Y (NPY)-like immunoreactivity in rat sensory neurons following peripheral axotomy. Neurosci Lett 124:200-203.
93. Wakisaka S, Kajander KC, Bennett GJ (1992) Effects of peripheral nerve injuries and tissue inflammation on the levels of neuropeptide Y-like immunoreactivity in rat primary afferent neurons. Brain Res 598:349-352.
94. Waxman SG (1999) The molecular pathophysiology of pain: abnormal expression of sodium channel genes and its contributions to hyperexcitability of primary sensory neurons. Pain [Suppl] 6:S133-S140.
95. Waxman SG, Kocsis JD, Black JA (1994) Type III sodium channel mRNA is expressed in embryonic but not adult spinal sensory neurons, and is reexpressed following axotomy. J Neurophysiol 72:466-470.
96. Waxman SG, Dib-Hajj S, Cummins TR, Black JA (1999) Sodium channels and pain. Proc Natl Acad Sci USA 96:7635-7639.
97. Wilcox GL (1991) Excitatory neurotransmitters and pain. In: Proceedings of the 6th World Congress of Pain (Bond MR, Charlton JE, Woolf CJ, eds), pp 97-117. Amsterdam: Elsevier.
98. Williamson EM, Evans FJ (2000) Cannabinoids in clinical practice. Drugs 60:1303-1314.
99. Woolf CJ (1997) Molecular signals responsible for the reorganisation of the synaptic circuitry of the dorsal horn after peripheral nerve injury: the mechanisms of tactile allodynia. In: Molecular neurobiology of pain (Borsook D, ed), pp 171-200. Seattle: IASP.
100. Woolf CJ, Costigan M (1999) Transcriptional and posttranslational plasticity and the generation of inflammatory pain. Proc Natl Acad Sci USA 96:7723-7730.
101. Wynick D, Thompson SW, McMahon SB (2001) The role of galanin as a multi-functional neuropeptide in the nervous system. Curr Opin Pharmacol 1:73-77.
102. Xu XJ, Wiesenfeld-Hallin Z, Villar MJ, Fahrenkrug J, Hokfelt T (1990) On the role of galanin, substance P and other neuropeptides in primary sensory neurons of the rat: studies on spinal reflex excitability and peripheral axotomy. Eur J Neurosci 2:733-743.
103. Yaksh TL, Harty GJ (1988) Pharmacology of the allodynia in rats evoked by high dose intrathecal morphine. J Pharmacol Exp Ther 244:501-507.